ArticleDrug safety2019

Correction to: Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn's Disease: An Integrated Analysis of Phase II/III Clinical Development Programs.

Subrata Ghosh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.